Related Experiment Video
Updated: Mar 11, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
11.2K
Implementation of inpatient models of pharmacogenetics programs
Larisa H Cavallari1, Craig R Lee2,3, Julio D Duarte4,5
1Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics, University of Florida, Gainesville, FL. lcavallari@cop.ufl.edu.
Summary
Pharmacists play a key role in implementing inpatient pharmacogenetics services, using genetic information to guide drug therapy. Their expertise is crucial for optimizing medication decisions and improving patient care through genotype-guided treatments.
Area of Science:
- Pharmacogenomics
- Clinical Pharmacy
- Genomic Medicine
Background:
- Pharmacogenetics is emerging in inpatient settings.
- Pharmacists' expertise in pharmacology and therapeutics is vital.
- Integrating genetic information into drug therapy is becoming increasingly important.
Purpose of the Study:
- To review operational elements for inpatient pharmacogenetics services.
- To highlight the pharmacist's role in genotype-guided drug therapy.
- To examine pharmacogenetics programs at three institutions.
Main Methods:
- Review of operational elements for pharmacogenetics services.
- Case examples from three institutions detailing pharmacist involvement.
- Analysis of reactive versus preemptive genotyping strategies.
- Adherence to Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines.
Main Results:
- Pharmacists are actively involved in leading and implementing pharmacogenetics programs.
- Pharmacists assist in interpreting genetic results and guiding prescribing decisions.
- Programs focus on optimizing antiplatelet and warfarin therapies.
- Reactive genotyping is the most feasible approach currently.
Conclusions:
- Pharmacists are essential for the clinical application of pharmacogenetics.
- Inpatient and ambulatory care pharmacists must be prepared to interpret and apply genetic test results.
- Pharmacist involvement facilitates genotype-guided drug therapy and optimizes patient outcomes.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
59
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
59
01:27Pharmacogenetics of Drug Metabolism: Overview
84
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
84
01:29Pharmacogenetics and Pharmacogenomics: Overview
109
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
109
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
81
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
81
01:27Principles of Pharmacogenetics: Types of Genetic Variants
69
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
69
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
59
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
59